Literature DB >> 8314031

Analysis of discrete phenotypes using a multipoint identity-by-descent method: application to Alzheimer's disease.

D E Goldgar1, C M Lewis, K Gholami.   

Abstract

The multipoint identity-by-descent method was developed to detect linkage to a specific chromosomal region through partitioning the genetic variance. This method has previously been applied to quantitative traits, and here is extended to a qualitative trait, where a dichotomous affected/unaffected status variable is transformed to a quantitative variable by incorporating covariates. This method is applied to the Alzheimer's disease data sets from Genetic Analysis Workshop 8, to investigate putative linkage to chromosomes 19 and 21. The multipoint identity-by-descent method is used to test for linkage through the qualitative trait, and for excess sharing of the chromosomal region among affected sibs. Results are compared to those of the affected-pedigree-member method and classical linkage analysis. None of these methods gave results showing clear linkage, with the only marginally significant results occurring for the Boston data set on chromosome 19 and the Duke data set for chromosome 21 using the multipoint identity-by-descent method.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8314031     DOI: 10.1002/gepi.1370100609

Source DB:  PubMed          Journal:  Genet Epidemiol        ISSN: 0741-0395            Impact factor:   2.135


  3 in total

1.  Affected-sib-pair analyses reveal support of prior evidence for a susceptibility locus for bipolar disorder, on 21q.

Authors:  S D Detera-Wadleigh; J A Badner; L R Goldin; W H Berrettini; A R Sanders; D Y Rollins; G Turner; T Moses; H Haerian; D Muniec; J I Nurnberger; E S Gershon
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

2.  Computation of identity-by-descent proportions shared by two siblings.

Authors:  S W Guo
Journal:  Am J Hum Genet       Date:  1994-06       Impact factor: 11.025

3.  Molecular linkage studies of bipolar disorder.

Authors:  W H Berrettini
Journal:  Dialogues Clin Neurosci       Date:  1999-06       Impact factor: 5.986

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.